Bicocca Open Archive

Logo unimib boa
VILLA, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.070
AS - Asia 5.233
EU - Europa 4.368
SA - Sud America 743
Continente sconosciuto - Info sul continente non disponibili 576
AF - Africa 125
OC - Oceania 5
Totale 22.120
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.467
SG - Singapore 1.735
IT - Italia 1.591
CN - Cina 884
HK - Hong Kong 819
VN - Vietnam 763
RU - Federazione Russa 616
BR - Brasile 549
CA - Canada 482
DE - Germania 468
IE - Irlanda 349
SE - Svezia 336
BD - Bangladesh 251
UA - Ucraina 216
GB - Regno Unito 204
IN - India 159
FR - Francia 149
ID - Indonesia 141
FI - Finlandia 99
AT - Austria 86
AR - Argentina 74
TR - Turchia 72
KR - Corea 66
IQ - Iraq 55
MX - Messico 53
ES - Italia 47
NL - Olanda 42
DK - Danimarca 41
ZA - Sudafrica 41
PL - Polonia 34
JP - Giappone 33
PK - Pakistan 33
SA - Arabia Saudita 32
PH - Filippine 31
EC - Ecuador 27
VE - Venezuela 27
UZ - Uzbekistan 23
CO - Colombia 22
IL - Israele 20
MA - Marocco 20
BE - Belgio 17
AE - Emirati Arabi Uniti 15
CH - Svizzera 15
MY - Malesia 15
CL - Cile 14
JM - Giamaica 13
CR - Costa Rica 11
IR - Iran 11
TN - Tunisia 11
AZ - Azerbaigian 10
HN - Honduras 10
PY - Paraguay 10
TW - Taiwan 10
UY - Uruguay 9
EG - Egitto 8
JO - Giordania 8
KE - Kenya 8
BG - Bulgaria 7
KZ - Kazakistan 7
OM - Oman 7
CZ - Repubblica Ceca 6
ET - Etiopia 6
RO - Romania 6
RS - Serbia 6
BO - Bolivia 5
DZ - Algeria 5
EU - Europa 5
GR - Grecia 5
LB - Libano 5
LT - Lituania 5
NP - Nepal 5
SN - Senegal 5
SV - El Salvador 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AL - Albania 4
GH - Ghana 4
GT - Guatemala 4
NI - Nicaragua 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
AU - Australia 3
EE - Estonia 3
HU - Ungheria 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BH - Bahrain 2
DM - Dominica 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
ML - Mali 2
MU - Mauritius 2
Totale 21.521
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.458
Ashburn 960
Singapore 956
Hong Kong 805
Fairfield 663
San Jose 609
Milan 546
Woodbridge 518
Houston 397
Wilmington 351
Dublin 338
Frankfurt am Main 336
Toronto 310
Chandler 270
New York 259
Council Bluffs 252
Cambridge 243
Seattle 243
Ho Chi Minh City 227
Santa Clara 206
Jacksonville 187
Los Angeles 187
Hanoi 180
Dallas 171
Chicago 158
Princeton 148
Beijing 135
The Dalles 120
Jakarta 118
Rome 118
Hefei 114
Dearborn 100
Columbus 95
Altamura 90
Lauterbourg 80
Buffalo 71
Lawrence 69
Nanjing 68
Moscow 67
Vienna 64
São Paulo 60
Seoul 56
Guangzhou 51
Phoenix 51
Ottawa 49
San Diego 48
Boardman 46
Orem 46
Helsinki 38
Montreal 36
Burlington 34
Brooklyn 32
Atlanta 30
Fremont 29
Lachine 29
Naples 28
Turin 28
Da Nang 27
Dong Ket 26
Lappeenranta 26
Shanghai 25
Baghdad 24
Grafing 24
London 24
Rio de Janeiro 24
Warsaw 24
Figino 23
Haiphong 23
Johannesburg 23
Tokyo 23
Chennai 22
Tashkent 22
Biên Hòa 21
Salt Lake City 20
Andover 19
Denver 19
Shenyang 18
Nanchang 17
Thái Nguyên 17
Dhaka 16
Munich 16
Paris 16
Stockholm 16
Hyderabad 15
Hải Dương 15
Mexico City 15
Washington 15
Brussels 14
Detroit 14
Hebei 14
Kent 14
Mumbai 14
Bologna 13
Brasília 13
Manchester 13
Memphis 13
San Francisco 13
Ha Long 12
Lahore 12
Norwalk 12
Totale 13.764
Salva come PNG Salva come JPEG
Nome #
CHRNA2 and nocturnal frontal lobe epilepsy: Identification and characterization of a novel loss of function mutation 601
Analysis of human papillomavirus (HPV) 16 variants associated with cervical infection in Italian women 464
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 457
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 418
Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer's disease: An update 418
Variants in CHRNB2 and CHRNA4 identified in patients with insular epilepsy 386
Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges 382
Molecular and imaging biomarkers in Alzheimer’s disease: A focus on recent insights 371
Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE) 370
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 366
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 364
Long Non-Coding RNAs and Related Molecular Pathways in the Pathogenesis of Epilepsy 362
Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing 361
Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics 346
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 342
TIMP1 Overexpression in Ovarian Cancer Spheroids: Implications for Prognosis, Resistance, and Metastatic Potential 326
Genetic architecture and molecular, imaging and prodromic markers in dementia with lewy bodies: State of the art, opportunities and challenges 323
Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease 312
Potassium channels and human epileptic phenotypes: An updated overview 304
Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms 300
The synergistic relationship between Alzheimer's disease and sleep disorders: An update 295
Epigenetics in Alzheimer’s Disease: A Critical Overview 277
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders 271
Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis 259
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis 257
Exome Sequencing in an ADSHE Family: VUS Identification and Limits 248
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases 242
Edaravone: A Novel Possible Drug for Cancer Treatment? 239
Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments 235
Circulating miRNAs as potential biomarkers in Alzheimer’s disease 235
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 234
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation 232
C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia 228
Ehlers-Danlos Syndrome classical type: A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype 225
From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder 224
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 224
Immunoreactivity of muscarinic acetylcholine M2 and serotonin 5-HT2B receptors, norepinephrine transporter and kir channels in a model of epilepsy 224
GSK3β genetic variability in patients with Multiple Sclerosis 222
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease 221
Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson’s disease: Molecular mechanisms connecting neuroinflammation to α-synuclein spreading pathology 221
Circulating miRNAs as potential biomarkers in Alzheimer's disease 217
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 217
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 215
Homology Modelling, Molecular Docking and Molecular Dynamics Simulation Studies of CALMH1 against Secondary Metabolites of Bauhinia variegata to Treat Alzheimer’s Disease 214
A novel role of cardiac inwardly rectifying potassium channels explaining autonomic cardiovascular dysfunctions in a cuprizone-induced mouse model of multiple sclerosis 214
GRN variability contributes to sporadic frontotemporal lobar degeneration 212
Psychosis in Parkinson’s Disease: A Lesson from Genetics 211
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects 210
Insights into Dysregulated Neurological Biomarkers in Cancer 209
Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis 208
Ehlers-Danlos syndromes and epilepsy: An updated review 204
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 202
C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder 199
Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder 198
FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration 198
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 194
Candidate gene analysis of selectin cluster in patients with multiple sclerosis 193
Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with alzheimer's disease 192
Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia 190
Investigating cardiac morphological alterations in a pentylenetetrazol-kindling model of epilepsy 186
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration 184
Unraveling the role of inwardly rectifying potassium channels in the hippocampus of an Aβ(1-42)-infused rat model of Alzheimer's disease 183
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 182
Causal Frontotemporal Lobar Degeneration mutations: a novel MAPT mutation associated with the clinical phenotype of Progressive nonfluent Aphasia 177
Tlr-mediated signal transduction and neurodegenerative disorders 175
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration 174
C9ORF72 repeat expansion is not detected in patients with multiple sclerosis 173
Blood-based biomarkers in mild behavioral impairment: an updated overview 172
Epileptic seizures in autosomal dominant forms of Alzheimer's disease 172
Arylsulfatase a (Asa) in parkinson’s disease: From pathogenesis to biomarker potential 172
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 169
Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease 164
Genetics and expression analysis of Sp4 transcription factor in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 164
Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration? 164
New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders 163
Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration 160
Novel exon 1 progranulin gene variant in Alzheimer's disease 160
A 45-year-old Italian male with p.(Gly1815Ser) FBN1 mutation causing a mild variant of Marfan syndrome: A case study 159
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 159
The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype 156
Transcription factor Sp1 is regulated by hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 151
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 148
Biomarkers for alzheimer’s disease: Where do we stand and where are we going? 143
MCP-1 A-2518G polymorphism: Effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels 142
Expression and genetic analysis of microRNAs involved in multiple sclerosis 136
Multi-omics for the understanding of brain diseases 134
Causal frontotemporal lobar degeneration mutations: a novel mutation in MAPT associated with non-fluent progressive aphasia phenotype 132
CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration 130
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration 129
Microfluidic platforms to unravel mysteries of alzheimer’s disease: How far have we come? 124
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 123
Ocular vascular changes: Choroidal thickness as an early biomarker for Alzheimer’s disease? 120
Misfolded Proteins and Cognitive Decline: Mechanistic Insights into Neurodegenerative Disorders 107
Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights 106
Application of molecular imaging as potential prognostic biomarker for triple-negative breast cancer (TNBC) 86
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice 77
Riluzole inhibits ovarian cancer cell migration by altering extracellular matrix structure 76
Functional study of a mutant α2 subunit of the neuronal nicotinic acetylcholine receptor linked to sleep-related generalized seizures with cognitive deficit 61
Identification of a novel missense variant in a family with autosomal dominant sleep-related hypermotor epilepsy (ADSHE) 41
Investigating the role of muscarinic acetylcholine M2 and serotonin 5-HT2B receptors, norepinephrine transporter and Kir channels in a pentylenetetrazol-kindling model of epilepsy 36
Totale 22.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.825
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022750 0 0 0 100 82 135 60 55 45 40 77 156
2022/20231.497 188 436 149 93 89 244 15 78 111 26 44 24
2023/20241.146 44 41 35 111 123 273 179 34 137 18 20 131
2024/20253.035 165 379 184 143 260 134 103 109 424 453 205 476
2025/20268.190 789 607 519 793 858 364 981 456 661 736 604 822
2026/20271.858 323 501 940 94 0 0 0 0 0 0 0 0
Totale 22.120